Related references
Note: Only part of the references are listed.High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population
Dimitrios L. Wagner et al.
NATURE MEDICINE (2019)
Use of the CRISPR/Cas9-based epigenetic gene activation system In Vivo: A new potential therapeutic modality
Samar H. Ibrahim et al.
HEPATOLOGY (2018)
CRISPR interference-based specific and efficient gene inactivation in the brain
Yi Zheng et al.
NATURE NEUROSCIENCE (2018)
Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA Population
Vijaya L. Simhadri et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation
Hsin-Kai Liao et al.
CELL (2017)
Rational design of low immunogenic anti CD25 recombinant immunotoxin for T cell malignancies by elimination of T cell epitopes in PE38
Ronit Mazor et al.
CELLULAR IMMUNOLOGY (2017)
A multifunctional AAV-CRISPR-Cas9 and its host response
Wei Leong Chew et al.
NATURE METHODS (2016)
Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses
Dan Wang et al.
HUMAN GENE THERAPY (2015)
HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status
Karen S. Anderson et al.
ORAL ONCOLOGY (2015)
TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T cell epitopes
Diego Chowell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
AAVrh.10 immunogenicity in mice and humans. Relevance of antibody cross-reactivity in human gene therapy
R. Thwaite et al.
GENE THERAPY (2015)
The immune epitope database (IEDB) 3.0
Randi Vita et al.
NUCLEIC ACIDS RESEARCH (2015)
Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA
Hiroshi Nishimasu et al.
CELL (2014)
Non-viral vectors for gene-based therapy
Hao Yin et al.
NATURE REVIEWS GENETICS (2014)
Removing T-cell epitopes with computational protein design
Chris King et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells
Ashley T. Martino et al.
BLOOD (2013)
Immune responses to AAV vectors: overcoming barriers to successful gene therapy
Federico Mingozzi et al.
BLOOD (2013)
A versatile protein microarray platform enabling antibody profiling against denatured proteins
Jie Wang et al.
PROTEOMICS CLINICAL APPLICATIONS (2013)
Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys
Federico Mingozzi et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks
Cole Trapnell et al.
NATURE PROTOCOLS (2012)
Adenoviral Vector Immunity: Its Implications and Circumvention Strategies
Yadvinder S. Ahi et al.
CURRENT GENE THERAPY (2011)
The Complex and Evolving Story of T cell Activation to AAV Vector-encoded Transgene Products
Lauren E. Mays et al.
MOLECULAR THERAPY (2011)
State-of-the-art gene-based therapies: the road ahead
Mark A. Kay
NATURE REVIEWS GENETICS (2011)
Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift
Jason R. Cantor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Enhancing the clinical potential of AAV vectors by capsid engineering to evade pre-existing immunity
Melissa Bartel et al.
FRONTIERS IN MICROBIOLOGY (2011)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors
Sylvie Boutin et al.
HUMAN GENE THERAPY (2010)
Adeno-Associated Virus-Mediated Gene Transfer to Nonhuman Primate Liver Can Elicit Destructive Transgene-Specific T Cell Responses
Guangping Gao et al.
HUMAN GENE THERAPY (2009)
NetMHCpan, a method for MHC class I binding prediction beyond humans
Ilka Hoof et al.
IMMUNOGENETICS (2009)
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
Steven J. Howe et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Enhancement of the CD8+ T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitope
Hoyin Mok et al.
VACCINE (2008)
Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities
Matthias Wolfl et al.
BLOOD (2007)
CD8+ T-cell responses to adeno-associated virus capsid in humans
Federico Mingozzi et al.
NATURE MEDICINE (2007)
Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy
Haiyan Jiang et al.
BLOOD (2006)
A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus
Magdalini Moutaftsi et al.
NATURE BIOTECHNOLOGY (2006)
Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice
CD Scallan et al.
BLOOD (2006)
Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response
CS Manno et al.
NATURE MEDICINE (2006)
The global burden of group A streptococcal diseases
JR Carapetis et al.
LANCET INFECTIOUS DISEASES (2005)
Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding
S Tenzer et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Rationally engineered therapeutic proteins with reduced immunogenicity
S Tangri et al.
JOURNAL OF IMMUNOLOGY (2005)
Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector
HB Gaspar et al.
LANCET (2004)
Elimination of an immunodominant CD4+ T cell epitope in human IFN-β does not result in an in vivo response directed at the subdominant epitope
VP Yeung et al.
JOURNAL OF IMMUNOLOGY (2004)
Viral interference with antigen presentation
JW Yewdell et al.
NATURE IMMUNOLOGY (2002)
Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy
S Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
M Cavazzana-Calvo et al.
SCIENCE (2000)
Share Paper
